- Home
- AMPH vs ESRT Comparison
AMPH vs ESRT Comparison
Compare AMPH & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- ESRT
- Stock Information
- Founded
- AMPH 1996
- ESRT 2011
- Country
- AMPH United States
- ESRT United States
- Employees
- AMPH N/A
- ESRT N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- AMPH Health Care
- ESRT Real Estate
- Exchange
- AMPH Nasdaq
- ESRT Nasdaq
- Market Cap
- AMPH 1.1B
- ESRT 1.2B
- IPO Year
- AMPH 2014
- ESRT 2013
- Fundamental
- Price
- AMPH $23.89
- ESRT $8.22
- Analyst Decision
- AMPH Hold
- ESRT Hold
- Analyst Count
- AMPH 5
- ESRT 2
- Target Price
- AMPH $38.00
- ESRT $10.65
- AVG Volume (30 Days)
- AMPH 507.4K
- ESRT 2.3M
- Earning Date
- AMPH 08-06-2025
- ESRT 07-23-2025
- Dividend Yield
- AMPH N/A
- ESRT 1.73%
- EPS Growth
- AMPH N/A
- ESRT 2.67
- EPS
- AMPH 2.77
- ESRT 0.30
- Revenue
- AMPH $730,659,000.00
- ESRT $762,039,000.00
- Revenue This Year
- AMPH $0.67
- ESRT $3.70
- Revenue Next Year
- AMPH $5.18
- ESRT $2.56
- P/E Ratio
- AMPH $8.26
- ESRT $26.72
- Revenue Growth
- AMPH 8.05
- ESRT 0.78
- 52 Week Low
- AMPH $22.64
- ESRT $6.56
- 52 Week High
- AMPH $53.96
- ESRT $11.62
- Technical
- Relative Strength Index (RSI)
- AMPH 34.01
- ESRT 49.62
- Support Level
- AMPH $22.81
- ESRT $7.98
- Resistance Level
- AMPH $25.04
- ESRT $8.30
- Average True Range (ATR)
- AMPH 0.67
- ESRT 0.27
- MACD
- AMPH -0.33
- ESRT -0.08
- Stochastic Oscillator
- AMPH 6.38
- ESRT 47.67
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.